1h Free Analyst Time
The inhaled nitric oxide market is forecasted to grow by USD 462.5 million during 2023-2028, accelerating at a CAGR of 10.77% during the forecast period. The report on the inhaled nitric oxide market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by use of inhaled nitric oxide in cardiac surgeries, increasing organic strategic initiatives, and rise in research and development activities.
The inhaled nitric oxide market is segmented as below:
By Application
- Neonatal respiratory treatment
- Chronic obstructive pulmonary disease (COPD)
- Acute respiratory distress syndrome (ARDS)
- Others
By Geographical Landscape
- North America
- APAC
- Europe
- South America
- Middle East and Africa
The report on the inhaled nitric oxide market covers the following areas:
- Inhaled nitric oxide market sizing
- Inhaled nitric oxide market forecast
- Inhaled nitric oxide market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global inhaled nitric oxide market: Air Liquide SA, Berkeley Life and L2G North America Inc., Beyond Air Inc, Geno Pharmaceuticals Pvt. Ltd., Getinge AB, Halma Plc, HumanN, Inspiration Healthcare Group Plc., Linde Plc, Mallinckrodt Plc, Merck KGaA, Moda Health Plan Inc., NIOX Group plc, SOL India Pvt Ltd, The Cigna Group, Uniscience Group, and VERO Biotech.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rise in the number of patients with copd."
According to the report, one of the major drivers for this market is the use of inhaled nitric oxide in cardiac surgeries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Air Liquide SA
- Berkeley Life and L2G North America Inc.
- Beyond Air Inc
- Geno Pharmaceuticals Pvt. Ltd.
- Getinge AB
- Halma Plc
- HumanN
- Inspiration Healthcare Group Plc.
- Linde Plc
- Mallinckrodt Plc
- Merck KGaA
- Moda Health Plan Inc.
- NIOX Group plc
- SOL India Pvt Ltd
- The Cigna Group
- Uniscience Group
- VERO Biotech
